CFO of Fennec Pharmaceuticals Buys More Shares Amid Market Dip, Reinforcing Long‑Term Confidence
Fennec Pharmaceuticals CFO’s latest insider buy signals long‑term confidence, hinting at a potential rebound amid market volatility and a strong oncology pipeline.
3 minutes to read